Insel Looks to Transformation of Diagnostics, Therapeutics

Insel added that statistics for morbidity and disability indicate that nearly 20 percent of all medical disability can be attributed to neuropsychiatric disease—more than are associated with cancer, heart disease, or stroke. “These numbers should give us real concern,” he emphasized. And he noted that when looking at the metric for “disability adjusted life years”—DALY, or the years lost to premature mortality and disability—the big driver is depression.

“This is partly because of prevalence and because it is so disabling, but also because it starts early,” Insel said. “Nearly 75 percent of adults with mental illness describe onset before age 25—that’s very different from cancer or heart disease. Up until the fifth or sixth decade, these [neuropsychiatric] disorders are the story.”

Insel outlined some of the problems that have hindered efforts “to bend the curve.” These include that diagnosis is limited to observable symptoms, and detection is almost invariably late; etiology of most mental illness is unknown; and prevention is not well developed for most disorders. And treatment is trial and error, without cures or vaccines.

Moreover, what is known as the mental health “system” is a poorly integrated maze of nonspecific pathways of care, with some people entering through the emergency department, criminal justice system, primary care system, or nonprofessional services. Diagnosis and treatment vary from provider to provider and from patient to patient, he noted.

Knowledge of the brain, despite enormous advances in recent years, is still in its infancy, Insel pointed out. “The brain is a world consisting of a number of unexplored continents and great stretches of unknown territory,” he said.

But he also described a promising future in which mental illness is reenvisioned as a disorder of brain circuitry that will be greatly advanced by President Obama’s BRAIN Initiative, announced in April 2013.

Research is revealing how chemical imbalances can lead to circuit dysfunction, and in turn to behavioral symptoms, and Insel said the connections that are emerging can be used in the development of diagnostic tests for brain disorders that are today diagnosed late through observation of symptoms. “We can now study the mind with the tools of neuroscience,” he said.

For instance, he presented evidence that is revealing attention-deficit/hyperactivity disorder to be a disorder of delayed cortical maturation. He also presented evidence of schizophrenia as a neurodevelopmental disorder with distinct risk and prodromal stages that allow for early intervention.

Finally, he described the NIMH Research Domain Criteria (RDoC) project, which he said will work in tandem with DSM. “DSM/ICD will continue to be the basis of clinical care,” he said. “RDoC is a framework for research in which NIMH will support researchers to deconstruct current diagnostic categories or identify dimensions that extend across categories. RDoC will develop through an information commons that integrates data from many sources, transforming the way we diagnose mental disorders in the future.” ■